| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Gen Counsel &Secretary | General Counsel | General Counsel +2 more
2 companies
Dubow Adam serves as a Gen Counsel &Secretary at DAWN and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 0 buys and 14 sells. Those positions are worth an estimated $1.5M at current prices.
Historically, Dubow Adam's trades have earned a middling insider score of 63/100 across 11 rated trades. Over a 12-month horizon, 62.5% of those trades were profitable, with an average 12-month return of +15.3%.
The biggest single holding is BMY (~$935K) as SVP,Chiefcompliance&Ethicsoff.. The recent filings there lean toward selling, a net 11,425 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 17, 2025 | DAWN Day One Biopharmaceuticals, Inc. | Gen Counsel &Secretary | Sale+OE | 4,319 | $8.91 | $38,502.59 | -6.5% | +34.4% | - | |
| Aug 18, 2025 | DAWN Day One Biopharmaceuticals, Inc. | Gen Counsel &Secretary | Sale+OE | 4,365 | $6.77 | $29,538.39 | -7.4% | +29.8% | - | |
| May 16, 2025 | DAWN Day One Biopharmaceuticals, Inc. | General Counsel | Sale+OE | 4,552 | $6.26 | $28,485.96 | -8.8% | 0.0% | - | |
| Feb 18, 2025 | DAWN Day One Biopharmaceuticals, Inc. | General Counsel | Sale+OE | 4,646 | $11.96 | $55,580.10 | -10.5% | -45.7% | -3.1% | |
| Nov 18, 2024 | DAWN Day One Biopharmaceuticals, Inc. | General Counsel | Sale+OE | 3,165 | $13.21 | $41,810.28 | -9.0% | -8.3% | -34.1% | |
| Aug 16, 2024 | DAWN Day One Biopharmaceuticals, Inc. | General Counsel | Sale+OE | 3,202 | $14.00 | $44,825.12 | -10.6% | +2.9% | -51.5% | |
| May 16, 2024 | DAWN Day One Biopharmaceuticals, Inc. | General Counsel | Sale+OE | 3,253 | $16.08 | $52,304.01 | -13.0% | -16.3% | -61.0% | |
| Feb 16, 2024 | DAWN Day One Biopharmaceuticals, Inc. | General Counsel | Sale+OE | 3,242 | $15.25 | $49,434.34 | -16.4% | +4.6% | -20.0% | |
| Nov 16, 2023 | DAWN Day One Biopharmaceuticals, Inc. | General Counsel | Sale+OE | 5,313 | $11.69 | $62,108.97 | -31.7% | +25.9% | +13.6% | |
| Jul 30, 2021 | BMY Bristol Myers Squibb Co | SVP,Chiefcompliance&Ethicsoff. | Sell | 2,466 | $67.90 | $167,441.40 | -15.2% | -15.1% | +12.1% |